The Pennsylvania Supreme Court has agreed to hear a case that could affect what evidence physicians may present in defense during medical malpractice suits.
Targeted steps can be taken to minimize future risks of lawsuits.
Malpractice liability reform would best be analyzed on a specialty-by-specialty basis.
There is a growing emphasis on provider responsibility with the increasing focus of the overprescribing of opioids.
Many in the medical field are wondering whether now may be the right time for medical malpractice reform.
A hostile medical litigation climate is one of the major problems with the existing malpractice insurance system, driving significant losses of access to quality health care.
A few doctors account for a disproportionately large number of paid malpractice claims.
Does anyone really benefit from defensive medicine?
Neurosurgeons practicing in high-risk liability states are very likely to have practiced defensive medicine.
Reductions in payment vary depending on the restrictiveness of the cap and the physician specialty.
Neurology Advisor Articles
- Case Study Report: Herbal Supplement Kratom Associated With Neonatal Abstinence Syndrome
- Seizure Monitoring Smartwatch Cleared for Use in Children
- Ocrelizumab Reduces Upper Extremity Disability Progression Risk in PPMS
- Can Early Initiation of Direct Oral Anticoagulants Prevent Recurrent AFib-Related Stroke?
- Online Family Problem-Solving Program May Improve Behavioral Outcomes in Older Children With TBI
- Very Early Mobilization After Stroke Does Not Improve Survival Over Usual Care
- Alemtuzumab Linked to Clinical and MRI Disease Remission in Multiple Sclerosis
- Cognitive Decline Worsens With Memantine, ChEIs in Patients With Alzheimer's
- Cervical Dysfunction Needs Clarification to Identify Link With Headache
- Levodopa Inhalation Powder Approved for Parkinson Disease
- Risk for Conversion of MS Varies With Different Therapies
- Breakdown of Blood-Brain Barrier May Drive Dementia
- FDA: Food Inspections to Resume Despite Ongoing Funding Lapse
- First Generic Version of Sabril Tablets Gets FDA Approval
- Supine Positioning After Greater Occipital Nerve Block May Improve Outcomes